Sian Bigora
Founder at PROCESSA PHARMACEUTICALS, INC.
Net worth: 50 748 $ as of 31/03/2024
Profile
Sian E.
Bigora is the founder of Processa Pharmaceuticals, Inc. where they currently hold the title of Chief Development & Regulatory Officer since 2017.
Dr. Bigora is also the founder of Promet Therapeutics LLC.
Dr. Bigora's former job positions include Vice President-Regulatory Affairs at Questcor Pharmaceuticals, Inc. from 2009 to 2015, Vice President-Regulatory Affairs at ICON plc, Vice President-Regulatory Affairs at AGI Therapeutics Plc from 2007 to 2009, and Chief Risk Officer at GloboMax LLC.
Dr. Bigora's education history includes a doctorate degree from the University of Maryland School of Pharmacy.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
01/01/2024 | 21,458 ( 1.26% ) | 50 748 $ | 31/03/2024 |
Sian Bigora active positions
Companies | Position | Start |
---|---|---|
PROCESSA PHARMACEUTICALS, INC. | Founder | 29/03/2011 |
Former positions of Sian Bigora
Companies | Position | End |
---|---|---|
QUESTCOR PHARMACEUTICALS INC | General Counsel | 01/01/2015 |
GloboMax LLC | Corporate Officer/Principal | - |
ICON PUBLIC LIMITED COMPANY | General Counsel | - |
Promet Therapeutics LLC
Promet Therapeutics LLC Pharmaceuticals: MajorHealth Technology Promet Therapeutics LLC engage in the clinical stage biotechnology company that develops drug products to treat patients who have suboptimal or no treatment alternatives. The company was founded on September 16, 2015 and is headquartered in Ellicott City, MD. | Founder | - |
University of Maryland School of Pharmacy | Corporate Officer/Principal | - |
Training of Sian Bigora
University of Maryland School of Pharmacy | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
ICON PUBLIC LIMITED COMPANY | Commercial Services |
PROCESSA PHARMACEUTICALS, INC. | Health Technology |
Private companies | 4 |
---|---|
Questcor Pharmaceuticals, Inc.
Questcor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Questcor Pharmaceuticals, Inc. was engaged in development, marketing and sale of prescription drugs. It operated as a biopharmaceutical company which focuses on the treatment of patients with serious, difficult-to-treat autoimmune and inflammatory disorders. The company's primary product was H.P. Acthar Gel, an injectable drug for the treatment of proteinuria in the nephrotic syndrome of the idiopathic type, or NS, the treatment of acute exacerbations of multiple sclerosis, or MS, in adults, the treatment of infantile spasms, or IS, in infants and children under two years of age, and the treatment of certain rheumatology related conditions, including the treatment of the rare and closely related neuromuscular disorders dermatomyositis and polymyositis. Questcor Pharmaceuticals was founded in September 1992 and was headquartered in Anaheim, CA. | Health Technology |
AGI Therapeutics Plc
AGI Therapeutics Plc Pharmaceuticals: MajorHealth Technology AGI Therapeutics Plc provides pharmaceutical services. The firm engages in development and commercialization of differentiated drug products to treat unmet medical needs, including conditions which qualify for orphan drug status. The company was founded by John Devane and Patrick Ashe in 2003 and is headquartered in Dublin, Ireland. | Health Technology |
GloboMax LLC | |
Promet Therapeutics LLC
Promet Therapeutics LLC Pharmaceuticals: MajorHealth Technology Promet Therapeutics LLC engage in the clinical stage biotechnology company that develops drug products to treat patients who have suboptimal or no treatment alternatives. The company was founded on September 16, 2015 and is headquartered in Ellicott City, MD. | Health Technology |
- Stock Market
- Insiders
- Sian Bigora